Skip to main content Skip to footer


Baylor Scott & White Charles A. Sammons Cancer Center – Dallas

  • Cancer Hates Pioneers

    We provide warriors with an arsenal of tools to defeat cancer—including immunotherapies that re-engineer your existing cells, giving your body the power to fight cancer from the inside. It's no wonder cancer hates us, and we intend to keep it that way.

About immune effector cell therapy

Building on its extensive experience in stem cell transplantation, the program has served as a springboard for developing a comprehensive immune effector cell therapy program. CAR-T therapy, an approach that reengineers a patient’s immune cells to be able to recognize and attack cancer cells, is a new and important building block for the immune effector cell therapy program.

For the past 30 years, adoptive cellular therapy with immune effector cells including a variety of lymphocytes, have been developed at research centers around the world, including Baylor University Medical Center, part of Baylor Scott & White Health. Chimeric Antigen Receptor (CAR) T cells have emerged from the lab as FDA-approved treatments for a variety of cancers. This includes some gene-modified T cells and natural (NK) cells. The future for effector cell therapy is bright, as it becomes the treatment of choice for many cancer patients. Baylor Dallas will continue to play a leading role in these pioneering efforts. Read more about CAR-T Cell Therapy on our medical professional website.


Contact Us

Our patient navigator will work with you to provide comprehensive and personalized cancer care. A patient navigator is ready to connect with you today.

Advancing cancer care with personalized CAR-T


Baylor Scott & White Charles A. Sammons Cancer Center – Dallas is the first center in North Texas to offer the first FDA approved chimeric antigen receptor (CAR) T cell therapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma (DLBCL), a type of non-Hodgkin’s lymphoma. CAR-T therapy allows a patient’s own immune system to help fight a disease. CAR-T clinical trials as well as other exciting immunotherapy applications are now available at Baylor Dallas. This important research has led to game-changing treatments that could improve the lives of cancer patients across Texas.

The treatment


CAR-T is a personalized therapy in which:

  • A patient’s own immune cells are removed from his or her body
  • Genetically reprogrammed
  • Infused back into the patient to seek and destroy cancer cells
Scroll To Top